Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Exact Sciences Cor (EXAS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 4,629,894
  • Shares Outstanding, K 118,200
  • Annual Sales, $ 99,380 K
  • Annual Income, $ -167,210 K
  • 36-Month Beta 0.73
  • Price/Sales 46.43
  • Price/Cash Flow 0.00
  • Price/Book 14.02

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.86 +15.68%
on 06/28/17
39.99 -2.05%
on 07/14/17
+4.18 (+11.95%)
since 06/21/17
3-Month
23.71 +65.20%
on 04/26/17
39.99 -2.05%
on 07/14/17
+15.24 (+63.69%)
since 04/21/17
52-Week
11.96 +227.51%
on 07/25/16
39.99 -2.05%
on 07/14/17
+27.02 (+222.39%)
since 07/21/16

Most Recent Stories

More News
Is a Beat in the Cards for ImmunoGen (IMGN) in Q2 Earnings?

ImmunoGen has made significant progress with its ovarian cancer pipeline candidate. Let's see if the company can come up with a beat this earnings season.

EXAS : 39.17 (+0.33%)
IMGN : 5.66 (-4.07%)
NVLS : 2.35 (-1.67%)
RHHBY : 32.2700 (+0.22%)
Why Exact Sciences (EXAS) Might Surprise This Earnings Season

Exact Sciences (EXAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

EXAS : 39.17 (+0.33%)
New Strong Buy Stocks for July 19th

New Strong Buy Stocks for July 19th

A : 61.37 (+0.64%)
EXAS : 39.17 (+0.33%)
CI : 174.23 (-0.15%)
CUNB : 36.95 (-0.27%)
FUN : 69.18 (-0.25%)
New Strong Buy Stocks for July 17th

New Strong Buy Stocks for July 17th

EXAS : 39.17 (+0.33%)
FOXF : 37.60 (-0.40%)
BANF : 108.95 (+3.91%)
BWP : 17.34 (+0.12%)
FUN : 69.18 (-0.25%)
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences

The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences

ENZ : 11.35 (-1.05%)
ALIM : 1.45 (-8.23%)
SRPT : 43.41 (+6.06%)
EXAS : 39.17 (+0.33%)
VRTX : 163.17 (+2.41%)
5 Top Multibagger Biotech Stocks to Buy in the 2nd Half

Draconian crackdown on drug prices easing out and likelihood of a series of buyouts will help innovation starved biotech companies to gain in the second half.

ENZ : 11.35 (-1.05%)
ALIM : 1.45 (-8.23%)
CELG : 137.74 (+1.05%)
EXAS : 39.17 (+0.33%)
SRPT : 43.41 (+6.06%)
VRTX : 163.17 (+2.41%)
REGN : 515.92 (-1.00%)
KITE : 109.15 (-0.67%)
ALXN : 131.79 (+1.53%)
Today's Research Reports on Stocks to Watch: BioCryst Pharmaceuticals and Exact Sciences

NEW YORK, NY / ACCESSWIRE / July 7, 2017 / U.S. markets continued to be dragged down by a selloff in technology stocks. The Dow Jones Industrial Average declined 0.74 percent to close at 21,320.04, while...

EXAS : 39.17 (+0.33%)
BCRX : 5.41 (-2.87%)
Technical Snapshots for These Medical Laboratories Stocks -- Exact Sciences, HTG Molecular Diagnostics, TrovaGene, and Novadaq Technologies

If you want a Stock Review on EXAS, HTGM, TROV or NVDQ then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Ahead of today's trading session, DailyStockTracker.com...

NVDQ : 11.71 (-0.17%)
TROV : 0.96 (-3.03%)
HTGM : 2.37 (+2.16%)
EXAS : 39.17 (+0.33%)
Why Exact Sciences (EXAS) Could Beat Earnings Estimates Again

Exact Sciences (EXAS) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.

EXAS : 39.17 (+0.33%)
Exact Sciences Shares Up 96.9% Since SmarTrend's Buy Recommendation (EXAS)

SmarTrend identified an Uptrend for Exact Sciences (NASDAQ:EXAS) on January 9th, 2017 at $17.81. In approximately 6 months, Exact Sciences has returned 96.91% as of today's recent price of $35.07.

EXAS : 39.17 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in...

See More

Support & Resistance

2nd Resistance Point 39.69
1st Resistance Point 39.43
Last Price 39.17
1st Support Level 38.81
2nd Support Level 38.45

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.